B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
about
Immunotherapy in autoimmune type 1 diabetesClinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.Consensus statement on the use of rituximab in patients with rheumatoid arthritisUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptorsTreatment with rituximab in idiopathic membranous nephropathy.Low-affinity Fcgamma receptors, autoimmunity and infection.Activating systemic autoimmunity: B's, T's, and tolls.Development of autoimmunity in lymphoma.Autoantibodies in neuromuscular autoimmune disorders.Acute infusion reactions induced by monoclonal antibody therapy.Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Dual targeting strategies with bispecific antibodies.The reversal of inhibitors in congenital hemophilia.Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.B cells participate in tolerance and autoimmunity through cytokine production.An acquired defect in IgG-dependent phagocytosis explains the impairment in antibody-mediated cellular depletion in Lupus.Indications of rituximab in autoimmune diseases.
P2860
Q27025619-AAF1C947-A0A8-45DA-BB24-68C5A9421E77Q34897189-E22D94A2-A24D-4A66-A0B4-72D434ECFD24Q35638252-4F45E6ED-8CB8-4776-B6C6-1B72FF1BECC5Q35638676-37CDCA9B-5125-4C98-B93C-DBF4BCFC12F9Q36171750-B1E0CD4C-7CFF-4198-9B0F-D45C8B0E214FQ36727307-C5675DE0-37A2-4318-83DA-E05230D9432DQ37511019-1D9485A3-6179-471D-9C2C-A34DDE369E36Q37578785-197AE2FC-F717-4620-A47F-7DB3DBF0ECA2Q37607510-A13E9095-5873-48FD-BE46-D52E5CFCFDD6Q37754707-B42DBA66-F1B0-4346-95C5-17E6623CC3DAQ37754738-F763F550-02DA-43D9-ABD8-8305E1148C20Q37821495-2D1455FC-9636-466F-9B60-15E159CB3AE2Q37883029-02CEA21D-B3D0-432B-9A8A-0DA71A3E46C6Q37997559-654BBA73-C5A4-46D1-AF2E-4E90DC5B8BDBQ38077139-547E8FC9-FF21-4868-8761-3DE83FFEB977Q38154934-B2599B40-0E9B-44A4-BBA3-3D583D9D24F9Q38163603-FBB50043-3321-47AD-B05D-8C57EC0E4743Q38546315-F745DD92-FD8D-486C-B7BD-5D83B1C6CCEAQ39925216-1B1BE053-D7D0-4044-96A6-EC602BE4671A
P2860
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
@ast
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
@en
type
label
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
@ast
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
@en
prefLabel
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
@ast
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
@en
P356
P1433
P1476
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEH618
P478
44 Suppl 2
P577
2005-05-01T00:00:00Z